Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition
暂无分享,去创建一个
J. Subramanian | T. Kuzel | S. Nanua | S. Raza | P. Rajakumar | A. Salahudeen | L. Shune | M. Levy | A. Paner | A. Masood | Trevor Christ | Samia Asif | Beth A. Gustafson | Drew Nedvad | Beth Gustafson
[1] S. Turner,et al. The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis , 2019, Cancers.
[2] H. Goldschmidt,et al. Germline Risk Contribution to Genomic Instability in Multiple Myeloma , 2019, Front. Genet..
[3] A. Shaw,et al. Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study. , 2018, The Lancet. Oncology.
[4] S. Benz,et al. Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer , 2018, Oncotarget.
[5] O. Stephens,et al. Kinase domain activation through gene rearrangement in multiple myeloma , 2018, Leukemia.
[6] David M. Jones,et al. ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy. , 2017, The oncologist.
[7] R. Cho,et al. Multiple Hereditary Infundibulocystic Basal Cell Carcinoma Syndrome Associated With a Germline SUFU Mutation. , 2016, JAMA dermatology.
[8] Nam Huh,et al. Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination , 2015, Proceedings of the National Academy of Sciences.
[9] Nam Huh,et al. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway , 2015, Nature Genetics.
[10] R. Pirker,et al. Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine? , 2015, Translational lung cancer research.
[11] T. Chevassut,et al. The Genetic Architecture of Multiple Myeloma , 2014, Advances in hematology.
[12] Jeffrey A. Engelman,et al. Tyrosine kinase gene rearrangements in epithelial malignancies , 2013, Nature Reviews Cancer.
[13] J. Carpten,et al. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. , 2012, Blood.
[14] Zhigui Ma,et al. ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript. , 2011, Pathology, research and practice.
[15] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[16] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[17] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[18] M. Cogné,et al. Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias , 2004, Journal of leukocyte biology.
[19] A. Rosenwald,et al. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. , 1999, Blood.
[20] Terry M Therneau,et al. Review of 1027 patients with newly diagnosed multiple myeloma. , 2003, Mayo Clinic proceedings.